Update on fibromyalgia syndrome

Bulletin on the Rheumatic Diseases

Volumn 48, Issue 5, 1999, Pages 1-4

  Wallace, Daniel J ^a   Shapiro, Sofia ^b   Panush, Richard S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE; CLONAZEPAM; CYCLOBENZAPRINE; DOXEPIN; FLUOXETINE; GLUCOCORTICOID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUBSTANCE P;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FIBROMYALGIA; HUMAN; JOINT EXAMINATION; NONARTICULAR RHEUMATISM; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SYNDROME; TREATMENT PLANNING;

FEMALE; FIBROMYALGIA; HUMANS; MALE; SYNDROME; UNITED STATES;

EID: 0032886898     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Hench PK. Nonarticular rheumatism, twenty-second rheumatism review: review of the American and English literature for the years 1973 and 1974. Arthritis Rheum 1976;19 (6 Suppl): 1081-8.
2. Russell IJ. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoskel Pain 1996;1:61-92.
3. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
4. Csillag C. Fibromyalgia: the Copenhagen declaration. Lancet 1992;340:663-4.
5. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
6. Konttinen YT, Kemppinen P, Segerberg M, et al. Peripheral and spinal neural mechanisms in arthritis with particular reference to inflammation and pain. Arthritis Rheum 1994;7:965-82.
7. Crofford LJ. The hypothalamic-pituitary-adrenal stress axis in the fibromyalgia syndrome. J Musculoskel Pain 1996;4:181-200.
8. Moldofsky H. The chronobiologic theory of fibromyalgia. J Musculoskel Pain 1996;1:49-59.
9. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
10. Markenson JA. Mechanisms of chronic pain. Am J Med 1996;101 Suppl 1A:6-18.
11. Abraham VJ, Remensone EI, Shapira IT, et al. What is the fibromyalgia syndrome and why is it important? Rheumatol Musculoskel Med Prim Care 1998;1:7-14.
12. Wallace DJ, Wallace JB. Making sense of fibromyalgia. New York: Oxford Univ Press, 1999.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington (DC): APA;1994. p. 445-70.
14. Goldenberg DL. Psychiatric illness and fibromyalgia. In: Pillemer SR, editor. The fibromyalgia syndrome: current research and future directions in epidemiology, pathogenesis and treatment. Binghamton (NY): Haworth Medical Press; 1995. p. 41-8.
15. Bennett R. Fibromyalgia, chronic fatigue and myofascial pain. Curr Opin Rheumatol 1998; 10:95-103.
16. Yunus MB. Fibromyalgia syndrome: clinical features and spectrum. J Musculoskel Pain 1994;2:5-21.
17. Wolfe F. The fibromyalgia syndrome: a consensus report on disability and fibromyalgia. J Rheumatol 1996;23:534-8.
18. MacFarlane GJ, Thomas E, Papageorgiou AC, et al. The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 1996;23:1617-20.